ATDC5 Cell Line小鼠畸胎癌细胞株-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
- 价 格:¥17952
- 货 号:ATDC5 Cell Line小鼠畸胎癌细胞株
- 产 地:北京
- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作QQ:1843439339 (微信同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
ATDC5 Cell Line小鼠畸胎癌细胞株
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心www.biovector.net
Cat No.: NTCC592575
Cell Line Name: | ATDC5 |
Keywords: | Mouse 129 teratocarcinoma AT805 derived |
Cell Line Description: | The chondrogenic cell line ATDC5 has been derived from teratocarcinoma AT805. Cells showed a sequential transition of phenotype in vitro. They encompass stages from mesenchymal condensation to calcification. Bone morphogenetic protein-2 (BMP-2) stimulated the sequential progression of early- and late-phase differentiation. Activation of parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor resulted in inhibition of this differentiation capacity. |
Species: | Mouse |
Tissue of Origin: | Unknown |
CellType: | Epithelial-like |
Growth Mode: | Adherent |
Karyotype: | Not specified |
Subculture Routine: | Split sub-confluent cultures (70-80%) i.e. seeding at 1-3 x10,000 cells/cm² using 0.25% trypsin or trypsin/EDTA;CO2; 37°C subculture every 2-3 days. |
Culture Medium: | DMEM: Ham's F12 (1:1) + 2mM Glutamine + 5% Foetal Bovine Serum (FBS). |
Country: | Japan |
References: | Exp. Cell Res 1998; 241:1, J Bone Miner Res 1997;12:1174 |
- 公告/新闻